Annual Long Term Debt
$29.58 B
-$764.53 M-2.52%
March 31, 2024
Summary
- As of February 26, 2025, TAK annual long term debt is $29.58 billion, with the most recent change of -$764.53 million (-2.52%) on March 31, 2024.
- During the last 3 years, TAK annual long term debt has fallen by -$12.24 billion (-29.28%).
- TAK annual long term debt is now -31.19% below its all-time high of $42.98 billion, reached on March 31, 2019.
Performance
TAK Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$29.96 B
-$1.04 B-3.35%
December 1, 2024
Summary
- As of February 26, 2025, TAK quarterly long term debt is $29.96 billion, with the most recent change of -$1.04 billion (-3.35%) on December 1, 2024.
- Over the past year, TAK quarterly long term debt has stayed the same.
- TAK quarterly long term debt is now -37.01% below its all-time high of $47.56 billion, reached on June 30, 2019.
Performance
TAK Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
TAK Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.5% | 0.0% |
| 3 y3 years | -29.3% | 0.0% |
| 5 y5 years | -31.2% | 0.0% |
TAK Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.3% | at low | -18.5% | +3.8% |
| 5 y | 5-year | -31.2% | at low | -31.6% | +3.8% |
| alltime | all time | -31.2% | >+9999.0% | -37.0% | >+9999.0% |
Takeda Pharmaceutical Company Limited Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $29.96 B(-3.4%) |
| Sep 2024 | - | $31.00 B(-1.1%) |
| Jun 2024 | - | $31.33 B(+5.9%) |
| Mar 2024 | $29.58 B(-2.5%) | $29.58 B(-2.9%) |
| Dec 2023 | - | $30.45 B(+3.3%) |
| Sep 2023 | - | $29.48 B(-1.4%) |
| Jun 2023 | - | $29.90 B(-1.4%) |
| Mar 2023 | $30.34 B(-10.6%) | $30.34 B(+1.6%) |
| Dec 2022 | - | $29.86 B(+3.5%) |
| Sep 2022 | - | $28.85 B(-8.8%) |
| Jun 2022 | - | $31.63 B(-6.8%) |
| Mar 2022 | $33.93 B(-18.9%) | $33.93 B(-7.7%) |
| Dec 2021 | - | $36.78 B(+2.5%) |
| Sep 2021 | - | $35.88 B(-9.5%) |
| Jun 2021 | - | $39.64 B(-5.2%) |
| Mar 2021 | $41.82 B(+0.3%) | $41.82 B(-3.4%) |
| Dec 2020 | - | $43.31 B(-1.2%) |
| Sep 2020 | - | $43.83 B(+4.9%) |
| Jun 2020 | - | $41.77 B(+0.2%) |
| Mar 2020 | $41.70 B(-3.0%) | $41.70 B(-1.5%) |
| Dec 2019 | - | $42.33 B(-5.8%) |
| Sep 2019 | - | $44.96 B(-5.5%) |
| Jun 2019 | - | $47.56 B(+10.7%) |
| Mar 2019 | $42.98 B(+363.5%) | $42.98 B(+95.4%) |
| Dec 2018 | - | $22.00 B(+184.4%) |
| Sep 2018 | - | $7.74 B(-14.0%) |
| Jun 2018 | - | $8.99 B(-3.1%) |
| Mar 2018 | $9.27 B(+72.9%) | $9.27 B(+4.7%) |
| Dec 2017 | - | $8.86 B(-0.1%) |
| Sep 2017 | - | $8.87 B(+5.5%) |
| Jun 2017 | - | $8.40 B(+56.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | $5.37 B(+11.7%) | $5.37 B(-15.7%) |
| Dec 2016 | - | $6.36 B(-12.9%) |
| Sep 2016 | - | $7.31 B(+1.6%) |
| Jun 2016 | - | $7.20 B(+49.8%) |
| Mar 2016 | $4.80 B(-8.4%) | $4.80 B(-8.2%) |
| Dec 2015 | - | $5.23 B(-0.3%) |
| Sep 2015 | - | $5.25 B(+1.7%) |
| Jun 2015 | - | $5.16 B(-1.6%) |
| Mar 2015 | $5.24 B(-23.4%) | $5.24 B(-14.3%) |
| Dec 2014 | - | $6.12 B(-6.3%) |
| Sep 2014 | - | $6.53 B(-5.7%) |
| Jun 2014 | - | $6.93 B(+1.2%) |
| Mar 2014 | $6.85 B(+10.6%) | $6.85 B(-9.1%) |
| Dec 2013 | - | $7.53 B(-6.8%) |
| Sep 2013 | - | $8.07 B(+47.2%) |
| Jun 2013 | - | $5.48 B(-11.4%) |
| Mar 2013 | $6.19 B(+69.2%) | $6.19 B(-1.5%) |
| Dec 2012 | - | $6.28 B(-9.7%) |
| Sep 2012 | - | $6.96 B(+83.3%) |
| Jun 2012 | - | $3.80 B(+3.8%) |
| Mar 2012 | $3.66 B(+1756.4%) | $3.66 B(+1756.4%) |
| Mar 2011 | $196.97 M(+18.7%) | $196.97 M(+18.7%) |
| Mar 2010 | $165.90 M(-0.8%) | $165.90 M(-0.8%) |
| Mar 2009 | $167.16 M(+861.5%) | $167.16 M |
| Mar 2007 | $17.38 M(-41.0%) | - |
| Mar 2006 | $29.49 M(-43.2%) | - |
| Mar 2005 | $51.88 M(+16.0%) | - |
| Mar 2004 | $44.73 M(+8.5%) | - |
| Mar 2003 | $41.23 M(-0.2%) | - |
| Mar 2002 | $41.32 M(-21.7%) | - |
| Mar 2001 | $52.74 M | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual long term debt?
- What is the all time high annual long term debt for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual long term debt year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly long term debt?
- What is the all time high quarterly long term debt for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly long term debt year-on-year change?
What is Takeda Pharmaceutical Company Limited annual long term debt?
The current annual long term debt of TAK is $29.58 B
What is the all time high annual long term debt for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual long term debt is $42.98 B
What is Takeda Pharmaceutical Company Limited annual long term debt year-on-year change?
Over the past year, TAK annual long term debt has changed by -$764.53 M (-2.52%)
What is Takeda Pharmaceutical Company Limited quarterly long term debt?
The current quarterly long term debt of TAK is $29.96 B
What is the all time high quarterly long term debt for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly long term debt is $47.56 B
What is Takeda Pharmaceutical Company Limited quarterly long term debt year-on-year change?
Over the past year, TAK quarterly long term debt has changed by $0.00 (0.00%)